Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0149871 (
deep vein thrombosis
)
12,364
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Lower rates of
deep vein thrombosis
have been noted following total hip replacement under epidural anesthesia in patients receiving exogenous epinephrine throughout surgery. To determine whether this is due to enhanced fibrinolysis or to circulatory effects of epinephrine, 30 patients scheduled for primary total hip replacement under epidural anesthesia were randomly assigned to receive intravenous infusions of either low dose epinephrine or phenylephrine intraoperatively. All patients received lumbar epidural anesthesia with induced hypotension and were monitored with radial artery and pulmonary artery catheters. Patients receiving low dose epinephrine infusion had maintenance of heart rate and cardiac index whereas both heart rate and cardiac index declined significantly throughout surgery in patients receiving phenylephrine (p = 0.0001 and p = 0.0001, respectively).
Tissue plasminogen activator
(
t-PA
) activity increased significantly during surgery (p < 0.005) and declined below baseline postoperatively (p < 0.005) in both groups. Low dose epinephrine was not associated with any additional augmentation of fibrinolytic activity perioperatively. There were no significant differences in changes in D-Dimer,
t-PA
antigen, alpha 2-plasmin inhibitor-plasmin complexes or thrombin-antithrombin III complexes perioperatively between groups receiving low dose epinephrine or phenylephrine. The reduction in
deep vein thrombosis
rate with low dose epinephrine is more likely mediated by a circulatory mechanism than by augmentation of fibrinolysis.
...
PMID:The hemodynamic and fibrinolytic response to low dose epinephrine and phenylephrine infusions during total hip replacement under epidural anesthesia. 144 77
Twenty-nine patients were operated on with the Charnley hip prosthesis. All the patients were given dextran 70 as thrombosis prophylaxis.
Deep vein thrombosis (DVT)
was diagnosed in 10 patients with the radioactive fibrinogen uptake test and phlebography. Variables of coagulation and fibrinolysis were studied before and after surgery.
Tissue plasminogen activator
(
t-PA
) activity in the plasma without venous occlusion decreased postoperatively, but there was no correlation with
DVT
. The
t-PA
activity in venous occlusion plasma was not reduced after surgery. Plasminogen activator inhibitor (PAI-1) levels were raised immediately postoperatively. There was a significant correlation between preoperative PAI-1 activity and development of postoperative
DVT
(P less than 0.05). Patients developing
DVT
had higher levels of PAI-1 postoperatively than patients not developing
DVT
. A defective fibrinolytic system, as defined by high PAI-1 activity, thus predisposed to postoperative
DVT
.
...
PMID:Thrombosis after hip replacement. Relationship to the fibrinolytic system. 247 86
The ability of streptokinase and urokinase to lyse intravascular fibrin-based clots is firmly established. However, there is a lack of enthusiasm for these agents because of serious haemorrhagic complications and a lack of controlled randomized studies indicating their efficacy. Thrombolytic therapy is suitable in only 15 per cent of patients with acute
deep venous thrombosis
. It restores the venous circulation to normal in up to 95 per cent of these patients if therapy is instituted within 5 days of the onset of symptoms. These patients have significantly fewer symptoms on follow-up than patients treated with heparin although the ability of thrombolytic therapy to preserve venous valvular function and to prevent the post-phlebitic syndrome is now in question. Thrombolytic therapy is as effective as heparin in preventing pulmonary embolism and may be superior in its treatment. Pulmonary haemodynamics are rapidly improved, diffusion capacity is restored and, although the evidence is inconclusive, long-term pulmonary hypertension may be prevented. Although the mortality rate is not decreased, controlled studies show that thrombolytic therapy may be beneficial in massive pulmonary embolism with clinical shock. Thrombolytic therapy is indicated for acute arterial and acute bypass graft occlusion when the surgical alternative is associated with a higher morbidity and mortality. Partial thrombolysis is achieved in up to 90 per cent of cases and the need for further therapeutic intervention is eliminated in one-third of the patients treated. New thrombolytic agents with greater specificity and potentially greater efficacy and fewer complications are being developed.
Tissue plasminogen activator
has been successfully used. Prourokinase, fibrin-seeking urokinase and acetylated streptokinase-plasminogen complex may expand the role of thrombolytic therapy in surgical practice.
...
PMID:The role of thrombolytic therapy in surgical practice. 265 13
The fibrinolytic system was studied after application of a pneumatic tourniquet in 22 patients undergoing elective orthopaedic surgery and during 20-min venous occlusion in 17 healthy subjects. Blood was sampled before anaesthesia (A), before operation (B) and after operation from the ipsilateral (C) and the contralateral (D) limb.
Tissue plasminogen activator
(
t-PA
) activity,
t-PA
antigen and
t-PA
activity/
t-PA
antigen ratio increased by, respectively, 557, 109 and 168% in the C samples as compared with A blood (all differences statistically significant). The
t-PA
activity and
t-PA
antigen increased slightly in the systemic circulation (B and D) but were significantly less in C than after venous occlusion. Fast-acting inhibitor of
t-PA
increased significantly in C (15%). During compression with a pneumatic tourniquet, mainly local fibrinolytic activation occurs, and this activation partly explains the low incidence of postoperative
deep venous thrombosis
after use of a tourniquet.
...
PMID:Fibrinolysis after application of a pneumatic tourniquet. 312 28
Tissue plasminogen activator
(
t-PA
) antigen concentrations were studied in 47 patients subjected to major abdominal surgery. The 17 patients, which developed postoperative
deep vein thrombosis
(
DVT
), diagnosed with the 125I-fibrinogen uptake test, had higher levels preoperatively, and on the sixth postoperative day, when the thrombi had already formed. The reduced fibrinolytic activity in patients with a predisposition to postoperative
deep vein thrombosis
is thus not related to any
t-PA
deficiency. The postoperative fibrinolytic shutdown may however partly be due to a drop in
t-PA
antigen levels, at least in the patients, which developed
DVT
.
...
PMID:Tissue plasminogen activator concentrations in major abdominal surgery. Relationship to postoperative deep vein thrombosis. 654 38
A 16-year-old boy was admitted to the hospital because of chest pain, dyspnea, and syncope. Physical examination revealed blood pressure of 100/60 mmHg, regular pulse of 120 beats/min, and respiratory rate of 30/min. Pulsation of the right ventricle was palpable in the left margin of the parasternum. An increased second sound was audible in the second inter-costal lesion of the left subclavicle mid-line. Results of blood tests were close to normal limits, except for slight leukocytosis and elevation of the LDH value. Analysis of artery blood gas showed hypoxia. The chest x-ray film showed cardiac enlargement. The value of systolic pulmonary artery pressure was estimated to be 47 mmHg by the cardiac echogram, which revealed enlargement of the right ventricle. Pulmonary embolism was suspected from the above findings. The value of pulmonary artery pressure was found to be 49/19 mmHg by Swan-Ganz catheter. Angiography of the pulmonary artery revealed filling defects of right in the right pulmonary artery.
Tissue plasminogen activator
was injected directly to the right pulmonary artery. After that, chest pain and dyspnea were relieved. In addition, arterial oxygen improved and pulmonary artery pressure decreased. At the 6th day after admission, the defect in the pulmonary artery angiography disappeared.
Deep vein thrombosis
of both femoral veins was recognized as a cause of pulmonary embolism by angiography of the femoral vein.
...
PMID:[A case of successful tissue plasminogen activator in young-onset pulmonary embolism]. 848 62